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In referring to a "rebound" in serum-cholesterol level
on resumption of normal diet by experimental subjects,
your article conveys a disturbing misinterpretation of our
observations. As indicated in fig. 20 of our report, we
tested this question by selecting the 10 experimental sub-
jects and the 11 control subjects who had had the best and
most prolonged adherence. During the 8 months before
termination of the experimental diet, these two subgroups
had nearly identical mean serum-cholesterol concentra-
tions. This must be attributed to chance, since the larger
groups from which the sub-samples were drawn displayed
lower mean levels among the experimental subjects than
among the controls (see fig. 5 of our report). On resump-
tion of the regular diet, the experimental subgroup dis-
played a prompt serum-cholesterol rise comparable in
magnitude to the fall seen at the start of the study. Their
levels were now higher than those of the control subgroup.
This was surely not a "rebound" phenomenon, but rather
an expression of the fact that non-dietary influences had set
serum-cholesterol levels higher in these 10 experimental
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SIR,-Dr. Kingsbury and his colleagues (Dec. 20, p. 1325)
make the following statement in their paper on poly-
unsaturated fatty acids and myocardial infarction: " Epstein
also found no relationship between plasma-cholesterol or
blood-sugar and new ischaemic events in patients with
myocardial infarction over a similar three to four-year
period ". I am afraid that this is a misquotation from the
presentation to the Royal Society of Medicine.1 Our data
from the Tecumseh Community Health Study did not
refer to such " new ischaemic events " but to new events
among persons initially free of manifest disease. This, I
hope, was quite apparent from the text. Moreover, it is
incorrect to say that we did not find a relationship between
plasma-cholesterol (or, rather, serum-cholesterol) and
blood-sugar, as stated by Dr. Kingsbury and his associates.
The actual findings, and some of their seeming incon-
sistencies, are carefully discussed in the original paper, and
I do not want to impose on your space to recapitulate them.
I will merely say that the numbers in the oldest and
youngest age-groups amongst men were small, and so was
the number of women who developed clinical events.
Furthermore, the new clinical events identified in detail in
my papery included angina pectoris and certain electro-
cardiographic ST-T wave changes which are less definite
" endpoints " than heart attacks. Even so, coronary heart-
disease and serum-cholesterol levels are, indeed, associated
amongst men in the important 40-59 age-group. With
regard to blood-sugar, the preliminary data in my paper to
the effect that persons with high blood-sugar are pre-
ferentially prone to death has now been further sub-
stantiated.2
Surely, there is no reasonable doubt about the association
between coronary heart-disease and serum-cholesterol.3 3
Similarly, it seems to be more and more likely that hyper-
glycasmia is also a predisposing factor towards coronary
disease.4,5 It is only to be expected that there will be, from
1. Epstein, F. H. Proc. R. Soc. Med. 1967, 60, 56.
2. Ostrander, L. D., Jr. Hyperglycemia and vascular disease in
Tecumseh, Michigan. Proceedings of the First International
Symposium on Early Diabetes, Marbella, Spain, Oct. 23-26, 1968.
New York (in the press).
3. Epstein, F. H. J. Am. med. Ass. 1967, 201, 795.
4. Epstein, F. H. Circulation, 1967, 36, 609.
5. Epstein, F. H. Minnesota Med. 1969, 52, 1271.
time to time, reports which are exceptions to the general
rule that elevated cholesterol, or, for that matter, blood-
pressure or glucose levels, predispose to ischaemic heart-
disease. Acheson and Florey 6 have pointed out very well
that a given predisposing factor is not necessarily operative
in all ecological settings where multiple genetic and
environmental influences interact. The urgent need is not
so much to argue over these associations but to test, by
means of preventive trials, whether they are causative.
To return to the paper by Dr. Kingsbury and his group,
it is perhaps not surprising that they find no association
between plasma-cholesterol and blood-sugar concentra-
tions and the degree of arterial disease. After all, their
subjects already had disease of such an advanced degree that
they were patients attending the hospital with manifesta-
tions of peripheral atherosclerosis. Even though a bio-
logical factor may cause the gradual development of arterial
disease, the extent of the disease in its late stages is not
necessarily related to the level of this factor at this advanced
stage. All this does not in the least detract from this and
earlier work by Dr. Kingsbury on the possible importance
of polyunsaturated fatty acids in the genesis of athero-
sclerosis.
FREDERICK H. EPSTEIN.







SIR,&mdash;We have seen three women with hereditary
haemorrhagic telangiectasia (H.H.T.) whose disease may
have been aggravated by oral oestrogens.
A 46-year-old woman of Spanish descent, admitted for
an unrelated cause, had had epistaxes since childhood,
anaemia of undetermined cause since age 15, and facial
telangiectasias and intermittent melaena since age 31. Her
paternal grandfather had bled to death from a nosebleed;
her father and two sons had typical cutaneous telangiec-
tasias. 21/2 years ago she began oral contraceptives; six
months later her facial lesions began enlarging, one becom-
ing quite disfiguring; and one year ago epistaxes recom-
menced.
A review of hospital records of patients with H.H.T.
revealed only one other who had been on oral contracep-
tives. This woman of 31 had telangiectasias of the skin and
mucous membranes, and her mother had a history of
epistaxes. The patient’s epistaxes began 5 years ago, while
she was taking ’ Estinyl’ (ethinyloestradiol) for regulation
of menstruation. They became worse during each of 3
pregnancies, and during the last, cautery was necessary 38
times. Despite a submucous resection, epistaxes continue
to limit her activity.
Subsequently we saw a 42-year-old Mexican-American
woman, whose mother and son had had troublesome
epistaxes. She had been taking an oral contraceptive’ Ovo’
for 4 years. 2 years ago she noticed telangiectasias for the
first time. Located on her finger tips and tongue, they
have since grown larger, and frequently bleed on minor
trauma. In the past year she has had occult gastrointestinal
bleeding and anxmia.
The records of six other nearby hospitals (over 500,000
admissions) were searched for other instances of women
with H.H.T. who were on oral contraceptives. None was
found. Recently, however, one of us examined a Mexican-
American woman with H.H.T. at Denver General Hospital
before and repeatedly during the first 10 months of oral
contraceptive therapy. Her lesions neither enlarged nor
6. Acheson, R. M., Florey, C. du V. Lancet, 1969, ii, 391.
